NCT00100841View on ClinicalTrials.gov

Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

July 31, 2011

Study Completion Date

July 31, 2011

Conditions
Adenocarcinoma of the RectumMucinous Adenocarcinoma of the ColonRecurrent Colon CancerRecurrent Rectal CancerSignet Ring Adenocarcinoma of the ColonStage IV Colon CancerStage IV Rectal Cancer
Interventions
BIOLOGICAL

cetuximab

Given IV

BIOLOGICAL

bevacizumab

Given IV

DRUG

oxaliplatin

Given IV

DRUG

leucovorin calcium

Given IV

DRUG

fluorouracil

Given IV

Trial Locations (1)

10467-2490

Montefiore Medical Center, The Bronx

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00100841 - Phase II Trial of FOLFOX6, Bevacizumab and Cetuximab in Patients With Colorectal Cancer | Biotech Hunter | Biotech Hunter